Search Results 51-60 of 9808 for Inhibition
Clinical Trials · Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma · More about research at Mayo ...
Akt inhibitor MK2206 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...
... inhibition by many inhibitors of other trypsins. Our lab has created prototype mesotrypsin inhibitors with improved affinity by using site-directed ...
Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies · Overview · Participation eligibility · Participating Mayo Clinic locations.
Akt inhibitor MK2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether bicalutamide is more ...
TP 0903 was shown to induce apoptosis in CLL B-cells taken directly from patients.TP-0903 was equally potent against CLL cells regardless of risk-factor. TP- ...
The purpose of this study is to assess the use of AR-42 in adult patients undergoing NF2-tumor removal. AR-42 is a small molecule which crosses the blood brain ...
Appropriate studies have not been performed on the relationship of age to the effects of C1 esterase inhibitor recombinant in the geriatric population. Safety ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.